FOSB-HDAC6 complex drives hepcidin-mediated ferroptosis in pulmonary ischemia-reperfusion injury
Background
Pulmonary ischemia-reperfusion (I/R) injury is a severe, life-threatening complication often seen after thoracic surgery, with current therapeutic options being limited. Ferroptosis, a form of iron-dependent regulated cell death, significantly contributes to the lung damage observed in I/R injury. However, the precise transcriptional mechanisms regulating ferroptosis in this context remain poorly understood. Understanding these pathways is crucial for developing targeted interventions to protect lung tissue.
Study Design
Researchers employed integrated murine pulmonary I/R models and hypoxia/reoxygenation (H/R)-treated lung epithelial cells to investigate the molecular mechanisms of ferroptosis. They utilized Transcriptomics, proximity-dependent biotin labeling (TurboID), chromatin immunoprecipitation (ChIP), co-immunoprecipitation (co-IP), and luciferase reporter assays to delineate the FOSB-HDAC6-HAMP axis. Functional rescue assays were also performed. Molecular markers were quantified using RT-qPCR, immunoblotting, and various biochemical kits to assess gene expression, protein levels, and cellular iron/ROS status.
Results
I/R injury significantly upregulated FOSB expression in lung tissues, which correlated with distinct alterations in ferroptosis markers. Specifically, there was a reduced expression of glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11), alongside an elevated expression of acyl-coenzyme A synthetase long-chain family member 4 (ACSL4). These changes were accompanied by an accumulation of ferrous iron (Fe2+) and increased levels of reactive oxygen species (ROS). Mechanistically, FOSB was found to directly bind the HAMP promoter at the -600/-300 bp region, thereby inducing hepcidin expression. Furthermore, HDAC6 physically interacted with FOSB and enhanced its occupancy on the HAMP promoter, which amplified hepcidin production. > HAMP overexpression reversed the protective effects observed when FOSB was knocked down in vitro, confirming its critical role in mediating ferroptosis. This establishes a clear link between the FOSB-HDAC6 complex and hepcidin-driven iron overload and ferroptosis.
Why It Matters
This study identifies a novel and targetable FOSB-HDAC6-HAMP axis that drives ferroptosis in pulmonary ischemia-reperfusion injury. Targeting this specific complex could offer a new therapeutic strategy for preventing or mitigating lung damage in patients undergoing thoracic surgery or experiencing other forms of lung I/R. By understanding the transcriptional regulation of hepcidin-mediated ferroptosis, clinicians might one day employ inhibitors of FOSB or HDAC6 to protect lung tissue. This research moves us closer to developing precise interventions that could significantly improve patient outcomes by reducing post-surgical complications and improving recovery.